Autologous Ovarian Cancer Immunogene-modified T Lymphocytes
autologous ovarian cancer immunogene-modified t lymphocytes
"A preparation of autologous immunogene modified T-lymphocytes (IgT) that have been genetically engineered to be specifically reactive to ovarian cancer (OC) cells, with potential antineoplastic and immunostimulating activities. Upon administration of the autologous OC-IgT cells, the T-cells recognize and induce specific toxicity in the OC cells."